Drug Companies Update Dec 2006
Mergers, acquisitions & Joint Ventures
- Amgen has acquired Avidia
- Barr Pharmaceuticals has acquired Croatian-based Pliva. Pliva is to remain a subsidiary.
- Bayer has acquired Schering AG. Schering AG has become Bayer Schering Pharma AG, a subsidiary of Bayer.
- Biomira, a biotechnology company specializing in cancer management, has acquired ProlX.
- Endo Pharmaceuticals has acquired RxKinetix, which will remain as a subsidiary.
- Forbes Medi-Tech has acquired TheraPei Pharmaceuticals.
- Genzyme has acquired AnorMED.
- NeuroSearch has acquired Carlsson Research. Carlsson Research is to remain a subsidiary and will change its name to NeuroSearch.
- Novartis has acquired Neutec Pharma, a UK pharmaceutical company.
- Pfizer has acquired Rinat Neuroscience.
- US biotechnology company Pharmion has acquired Cabrellis Pharmaceuticals a clinical-stage private oncology company.
- Pharmos has acquired Vela Pharmaceuticals.
- Watson Pharmaceuticals has acquired Andrxto become the 3rd largest US generic pharmaceutical company.
New Companies
- ADImmune, also known as the Kuo Kwang Biotechnology Company, was established in 1969. It develops human vaccines.
- Amorcyte is a therapeutics company pursuing cellbased therapies for cardiovascular diseases.
- Canadian biotechnology company Antibe Therapeutics is developing therapeutics based on small vasoactive components for the treatment of chronic diseases.
- Antoxis is a biotechnology company focused on the synthesis of therapeutic anti-oxidants for the treatment of stroke and Alzheimer's disease.
- Germany based AplaGen Biopharmaceuticals developing peptides from marketed peptide drugs.
- Ash Access Technology is a US pharmaceutical and medical device company.
- Bellicum Pharmaceuticals is a privately owned US company which uses immunotherapeutic approaches for the treatment of cancer.
- Biotherapix specializes in human antibodies and related molecules for the treatment of infectious, degenerative and inflammatory diseases.
- Cardium Therapeutics is a medical technology company focused on the development of cardiovascular and related indications.
- CMP Therapeutics is a biopharmaceutical company that is developing a form of micronised chitin for the treatment of allergies and infectious diseases.
- Covalon Technologies is a Canadian medical biosystems company that has initiated a gene therapy programme for ischaemia.
- Digna Biotech is a spin-off of the Centre of Applied Medical Research of the University of Nevarra.
- Swedish pharmaceutical company DuoCort specializes in developing glucocorticoid replacement therapies for chronic renal insufficiency patients.
- EKR Therapeutics is a US company focused on symptom management oncology products.
- GangaGen is a biotechnology company focused on the development of bacteriophage-based products for the prevention and treatment of bacterial infections.
- Ikaria is a Seattle-based biotechnology company, developing breakthrough products for critical care.
- Macroflux was spun out of Alza (Johnson & Johnson) to develop its eponymous Macroflux transdermal drug delivery system.
- MediVas is a US drug delivery company.
- Mimetogen Pharmaceuticals develops small molecule peptidomimetics for the treatment of small cell lung cancer and glaucoma.
- NovaCardia in-licences and develops clinical stage small molecule therapeutics for cardiovascular disease.
- US biopharmaceutical company Nucana focuses on ethical products for cancer and autoimmune therapy.
- Established in 2004 by the Baylor Health Care System, ODC Therapy develops cancer immunotherapeutics.
- Osteologix, a Danish company, is developing compounds for treating bone and cartilage disorders.
- RhinoCyte develops diagnostic tools and therapeutics for multiple degeneration and traumatic diseases.
- Sangretech Asia Biomedical Corporation, based in the Philippines, specializes in the development of cellular therapies for cancer and other conditions. Norwegian Santosolve is developing novel analgaesics.
- UK based pharmaceutical firm Sareum is developing novel drugs for cancer treatment.
- SCOLR Pharma is a Washington-based company with expertise in formulation and drug-delivery technology.
- Sernova has exclusive rights for the use of Sertoli cells and is developing translated pig islet and Sertoli cells for reversing insulin-dependant diabetes.
- Sertoli Technologies is a cellular therapy company with platform technology to enable the therapeutic transplantation of cells and cell-based gene therapy.
- Synphora is a privately-owned biotechnology company focussed on prostaglandin technology.
- Syntaxin is developing bacterial-based protein therapeutics for neurological, respiratory and metabolic disease.
- Tacere Therapeutics is investigating compounds to treat infectious diseases.
- Taligen Therapeutics commercializes technology developed by the University of Colorado for the treatment of inflammatory disease.
- Traxion Therapeutics is developing small-molecule drugs for the treatment of intractable pain.
- Zestra Laboratories is a US healthcare company formerly known as QualiLife Pharmaceuticals.
